BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report)’s share price was up 2.1% on Monday . The stock traded as high as $0.89 and last traded at $0.89. Approximately 508,175 shares changed hands during mid-day trading, an increase of 27,236% from the average daily volume of 1,859 shares. The stock had previously closed at $0.87.
BriaCell Therapeutics Price Performance
The company has a 50 day moving average of $0.80 and a 200-day moving average of $1.15. The company has a market cap of $594,362.80, a P/E ratio of -0.20 and a beta of 1.09.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Further Reading
- Five stocks we like better than BriaCell Therapeutics
- Dividend Payout Ratio Calculator
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Comparing and Trading High PE Ratio Stocks
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
